Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/2971
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats

AuthorsSerrano-Mollar, Anna CSIC ORCID; Closa, Daniel CSIC ORCID; Morcillo, Esteban J.; Bulbena, Oriol CSIC
KeywordsPulmonary fibrosis
Bleomycin
Rat
N-acetylcysteine
Inflammation
Issue Date26-Mar-2003
PublisherWiley-Blackwell
CitationBritish Journal of Pharmacology 138(6): 1037–1048 (2003)
AbstractThis study examines the activity of the antioxidant N-acetylcysteine on bleomycin-induced pulmonary fibrosis in rats with emphasis on the early inflammatory phase. Rats receiving N-acetylcysteine (300 mg kg−1 day−1, intraperitoneal) had less augmented lung wet weight, and lower levels of proteins, lactate dehydrogenase, neutrophil and macrophage counts in bronchoalveolar lavage fluid and lung myeloperoxidase activity with a betterment of histological score at 3 days postbleomycin. A diminished lung GSH/GSSG ratio and augmented lipid hydroperoxides were observed 3 days postbleomycin. These changes were attenuated by N-acetylcysteine. Alveolar macrophages from bleomycin-exposed rats released augmented amounts of superoxide anion and nitric oxide. N-Acetylcysteine did not modify superoxide anion generation but reduced the increased production of nitric oxide. N-Acetylcysteine suppressed the bleomycin-induced increased activation of lung NF-κB (shift assay and immunohistochemistry), and decreased the augmented levels of the early inflammatory cytokines, tumour necrosis factor-α, interleukin-β, interleukin-6 and macrophage inflammatory protein-2 observed in bronchoalveolar lavage fluid at 1 and 3 days postbleomycin exposure. At 15 days postbleomycin, N-acetylcysteine decreased collagen deposition in bleomycin-exposed rats (hydroxyproline content: 6351±669 and 4626±288 μg per lung in drug vehicle- and N-acetylcysteine-treated rats, respectively; P<0.05). Semiquantitative histological assessment at this stage showed less collagen deposition in N-acetylcysteine-treated rats compared to those receiving bleomycin alone. These results indicate that N-acetylcysteine reduces the primary inflammatory events, thus preventing cellular damage and the subsequent development of pulmonary fibrosis in the bleomycin rat model.
Publisher version (URL)http://dx.doi.org/10.1038/sj.bjp.0705138
URIhttp://hdl.handle.net/10261/2971
DOI10.1038/sj.bjp.0705138
ISSN0007-1188
Appears in Collections:(IIBB) Artículos

Files in This Item:
File Description SizeFormat
In vivo antioxidant.pdf467,57 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

31
checked on Jan 14, 2022

SCOPUSTM   
Citations

107
checked on Jan 18, 2022

WEB OF SCIENCETM
Citations

96
checked on Jan 20, 2022

Page view(s)

376
checked on Jan 19, 2022

Download(s)

338
checked on Jan 19, 2022

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.